Product Code: RP-ID-10013253 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10013253
Market Overview:
Global Continuous Glucose Monitoring Systems Market Size Study, By Components (Transmitters & Receivers, Integrated Insulin Pumps, and Sensors), By Demographic (Child Population, Adult Population), By End Users (Home Healthcare, Diagnostic Centers/Clinics, ICUs), and Regional Forecasts, 2017-2025
Global Continuous Glucose Monitoring Systems Market industry valued approximately USD 610.0 million in 2016 is anticipated to grow with a healthy growth rate of more than 40.20% over the forecast period 2017-2025. Continuous Glucose Monitoring System is utmost important across all age groups for real time continuous glucose monitoring and manage diabetes effectively. The major factors driving the growth is due to increasing diabetic population, increase in healthcare expenditure, increasing CGMS affordability, and increasing focus on research and development.
Earphones & Headphones industry has largely experienced technological advancements such as self-monitoring blood glucose (SMBG) devices, and the detection of hypoglycemic and hyperglycemic events by CGMS etc. These developments are expected to continue over the forecast period. Rising diabetic population and integration of technology make the manufacturer to offer better monitoring system for measuring accurate glucose level. Such advancements will drive the market growth in the coming years.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
Components:
 Integrated insulin Pumps
 Transmitters & Receivers
 Sensors
Demographic:
 Child Population
o Less than 14 years
 Adult Population
o More than 14 years
End-Users:
 Diagnostics Centers/Clinics
 Home Healthcare
 ICUs
Regions:
 North America
o U.S.
o Canada
 Europe
o UK
o Germany
 Asia Pacific
o China
o India
o Japan
 Latin America
o Brazil
o Mexico
 Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2015
Base year – 2016
Forecast period – 2017 to 2025
Some of the key manufacturers involved in the market are Abbott laboratories, Dexcom Inc., Glysens Incorporated, Johnson & Johnson, Medtronic Plc, AgaMatrix Inc., Arkray USA Inc. Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.
Target Audience of the Continuous Glucose Monitoring Systems Market Study:
 Key Consulting Companies & Advisors
 Large, medium-sized, and small enterprises
 Venture capitalists
 Value-Added Resellers (VARs)
 Third-party knowledge providers
 Investment bankers
 Investors
Dexcom Inc.
Echo Therapeutics Inc.
Glysens Incorporated
Johnson & Johnson
Medtronic plc
Senseonics Holdings Inc.
F. Hoffmann-La Roche Ltd
Agamatrix Inc.
Glucovation
Related Reports
Proof of Quality & Reliability
